These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 18805030)

  • 1. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.
    Pusterla N; David Wilson W; Madigan JE; Ferraro GL
    Vet J; 2009 Jun; 180(3):279-89. PubMed ID: 18805030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine herpesvirus 1 myeloencephalopathy.
    Pusterla N; Hussey GS
    Vet Clin North Am Equine Pract; 2014 Dec; 30(3):489-506. PubMed ID: 25300635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine herpesvirus myeloencephalopathy: unravelling the enigma.
    Nugent J; Paillot R
    Vet J; 2009 Jun; 180(3):271-2. PubMed ID: 19141371
    [No Abstract]   [Full Text] [Related]  

  • 4. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France.
    Pronost S; Léon A; Legrand L; Fortier C; Miszczak F; Freymuth F; Fortier G
    Vet Microbiol; 2010 Oct; 145(3-4):329-33. PubMed ID: 20427133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
    Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
    Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine Herpesvirus-1 Myeloencephalopathy, an Emerging Threat of Working Equids in Ethiopia.
    Negussie H; Gizaw D; Tessema TS; Nauwynck HJ
    Transbound Emerg Dis; 2017 Apr; 64(2):389-397. PubMed ID: 26010868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007).
    Perkins GA; Goodman LB; Tsujimura K; Van de Walle GR; Kim SG; Dubovi EJ; Osterrieder N
    Vet Microbiol; 2009 Nov; 139(3-4):375-8. PubMed ID: 19615831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak.
    Traub-Dargatz JL; Pelzel-McCluskey AM; Creekmore LH; Geiser-Novotny S; Kasari TR; Wiedenheft AM; Bush EJ; Bjork KE
    J Vet Intern Med; 2013; 27(2):339-46. PubMed ID: 23398291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine Herpesvirus-1 Myeloencephalopathy.
    Pusterla N; Hussey GS; Goehring LS
    Vet Clin North Am Equine Pract; 2022 Aug; 38(2):339-362. PubMed ID: 35811201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
    Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
    Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine herpesvirus-1 consensus statement.
    Lunn DP; Davis-Poynter N; Flaminio MJ; Horohov DW; Osterrieder K; Pusterla N; Townsend HG
    J Vet Intern Med; 2009; 23(3):450-61. PubMed ID: 19645832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two outbreaks of neuropathogenic equine herpesvirus type 1 with breed-dependent clinical signs.
    Barbić L; Lojkić I; Stevanović V; Bedeković T; Starešina V; Lemo N; Lojkić M; Madić J
    Vet Rec; 2012 Mar; 170(9):227. PubMed ID: 22262701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of equine herpesvirus myeloencephalopathy in France: a clinical and molecular investigation.
    Pronost S; Legrand L; Pitel PH; Wegge B; Lissens J; Freymuth F; Richard E; Fortier G
    Transbound Emerg Dis; 2012 Jun; 59(3):256-63. PubMed ID: 21975071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the role of mules as silent shedders of EHV-1 during an outbreak of EHV-1 myeloencephalopathy in California.
    Pusterla N; Mapes S; Wademan C; White A; Estell K; Swain E
    Vet Rec; 2012 May; 170(18):465. PubMed ID: 22472540
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?
    Hussey GS; Giessler KS
    Vet J; 2022 Apr; 282():105827. PubMed ID: 35405348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.